ClinicalTrials.Veeva

Menu

Hyperfibrinogenemia After Major Trauma

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Major Trauma

Treatments

Procedure: Blood samples

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Assessment of the evolution of fibrinogen plasma level within the first ten days after major trauma in order to determine prevalence of hyperfibrinogenemia (Fg > 4 g/L) and its time to onset.

Full description

In this study, investigators daily investigate fibrinogen plasma levels and fibrinogen antigen in severe trauma patients (Injury severity score > 15) within the first ten days. Investigators then modelize hyperfibrinogenemia profiles according to severity of injuries and physiopathologic mechanisms. Finally, investigators determine predisposing risk factors to develop hyperfibrinogenemia and assess the impact of fibrinogen replacement therapy in initial phase of management of major trauma.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18 years old.
  • Polytrauma with ISS Score > 15
  • Hospitalized patients in reanimation unit < 4h after trauma
  • Informed consent

Exclusion criteria

  • Patients in another study
  • Pregnant or lactating women

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 1 patient group

Severe trauma patients
Experimental group
Description:
All severe trauma patients (ISS\>15) admitted in our trauma center Blood samples (additional blood tubing)
Treatment:
Procedure: Blood samples

Trial contacts and locations

1

Loading...

Central trial contact

Pauline PD DERAS, MD; Sophie SB BRINGUIER, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems